| HOME >> BIOLOGY >> TECHNOLOGY |
Vaccination after discontinuation of antiretroviral treatment 139
Recombinant HIV proteins 140
DNA vaccines for HIV/AIDS 140
Epitope-based DNA vaccines against HIV 141
Limitations and needs of HIV vaccines 141
Innovations in HIV/AIDS vaccine 142
Attenuated rabies virus-based vaccine for HIV 142
Combination of a prime vaccine and booster vaccine 142
Dendritic cell-based vaccine for HIV 142
MVA nef vaccine 143
Peptide-based vaccine for HIV 143
Personalized vaccine for HIV 143
Transdermal nanoparticles for immune enhancement in HIV 144
Vaccine to prevent HIV entry at the mucosal level 144
Cell therapy for HIV/AIDS 144
hESCs converted to T-cells for treatment of HIV infection 145
Transplantation of genetically modified hematopoietic cells 145
Transplantation of genetically modified T cells 145
Overlapping Peptide-pulsed Autologous Cells 146
Antisense approaches to AIDS 146
Antisense oligodeoxynucleotides 146
Antisense efforts with PNA constructs 146
RNA decoys 147
Ribozymes 147
RNAi applications in HIV/AIDS 148
A multiple shRNA approach for silencing of HIV-1 148
Aptamer-medi
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |